Skip to main navigation
Header Menu
  • About Us
    • Who We Are
    • Our Team
    • Board of Directors
  • Science
    • Prescription Digital Therapeutics
    • Product Pipeline
    • Clinical Trials
    • Research
  • Products
    • reSET® & reSET-O®
    • Somryst®
  • News
    • Press Releases
    • Pear in the News
    • Pear Prescription Digital Therapeutics (PDT) Digest
  • Investors
    • IR Home
    • News & Events
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Shareholder Services
  • Careers
    • Our Values
    • Our Culture
    • Open Positions
Top Links
Contact Us
Pear Therapeutics, Inc.

SEC Filing Details

IR Sub Menu - Financial Information
SEC FilingsQuarterly ResultsAnnual Reports

Document Details

Form
S-4/A
Filing Date
September 8, 2021
Document Date
September 8, 2021
Form Description
Pre-effective amendment to an S-4 filing
Filing Group
Registration Statements
Company
Pear Therapeutics, Inc.
Issuer
PEAR THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT

 

Back
Pear Therapeutics, Inc.
  • Boston
    200 State Street
    Boston, MA 02109
  • San Francisco
    201 Mission Street
    San Francisco, CA 94105
Footer Email
  • Email Us
Footer Social
  • Twitter
  • LinkedIn
  • © 2023 Pear Therapeutics, Inc. All Rights Reserved.
  • Privacy Policy
  • Code of Conduct